Auteur H. HAGAN

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

An interview study of participants in the Tacoma, Washington, syringe exchange

H. HAGAN ; D. C. DES JARLAIS ; D. PURCHASE ; S. R. FRIEDMAN ; T. REID ; T. A. BELL | 1993
Dans Addiction (Vol.88, n°12, December 1993) Article : Périodique

FRANÇAIS : Nous faisons ici le compte rendu de la mise en oeuvre et de l'efficacité potentielle de la plus longue opération d'échange de seringues fonctionnant aux USA, de même que nous comparons nos résultats à ceux d'études portant sur des p[...]

Plus d'info

Ajouter à la sélection

Are females who inject drugs at higher risk for HIV infection than males who inject drugs: An international systematic review of high seroprevalence areas

D. C. DES JARLAIS ; J. P. FEELEMYER ; S. N. MODI ; K. ARASTEH ; H. HAGAN | 2012
Dans Drug and Alcohol Dependence (Vol.124, n°1-2, July 2012) Article : Périodique

Objective: There are multiple reasons why females who inject drugs may be more likely to become infected with HIV than males who inject drugs. Where this is the case, special HIV prevention programs for females would be needed. Design: Internat[...]

Plus d'info

Ajouter à la sélection

Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users : a quasi-randomised trial

D. C. DES JARLAIS ; D. PAONE ; MILLIKEN J. ; C. F. TURNER ; H. MILLER ; GRIBBLE J. ; SHI Q. ; H. HAGAN ; S. R. FRIEDMAN | 1999
Périodique

FRANÇAIS : Une méthode d'entretien (audio-CASI) par ordinateur où les questions sont posées sur l'écran et en même temps à l'aide d'un casque audio et les réponses données par sélection sur le clavier, permet de réduire les sous-déclarations. D[...]

Plus d'info

Ajouter à la sélection

Can intranasal drug use reduce HCV infection among injecting drug users?

D. C. DES JARLAIS ; H. HAGAN ; K. ARASTEH ; C. McKNIGHT ; S. SEMAAN ; D. C. PERLMAN | 2011
Dans Drug and Alcohol Dependence (Vol.119, n°3, December 2011) Article : Périodique

BACKGROUND: Preventing HCV infection among people who inject drugs is a difficult public health challenge. We examined the potential role of intranasal drug use in reducing HCV acquisition. METHODS: Subjects were recruited from IDUs entering t[...]

Plus d'info

Ajouter à la sélection

A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States

S. M. STRAUSS ; J. M. ASTONE ; D. C. DES JARLAIS ; H. HAGAN | 2004
Périodique

ENGLISH : Drug treatment programs are uniquely situated to screen patients for antibodies for hepatitis C virus (HCV), an infectious disease that has reached epidemic proportions among drug users. This paper compares the accessibility and pati[...]

Plus d'info

Ajouter à la sélection

Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing

S. M. JENNESS ; H. HAGAN ; K. L. LIU ; T. WENDEL ; C. S. MURRILL | 2011
Dans Substance Use and Misuse (Vol.46, n°2-3, 2011) Article : Périodique

Sterile syringe access is an important means to reduce HIV risk, but many injection drug users (IDU) who obtain syringes from sterile sources continue to share syringes. We examined the factors associated with continuing syringe sharing in New Y[...]

Plus d'info

Ajouter à la sélection

Lien externe

Current and emerging research needs in studying the NYC HIV-drug use epidemic

S. DEREN ; H. HAGAN ; S. FRIEDMAN ; D. C. DES JARLAIS ; D. PERLMAN ; M. GWADZ ; C. CLELAND ; A. OSBORNE ; J. LUNIEVICZ | 2011
Dans Substance Use and Misuse (Vol.46, n°2-3, 2011) Article : Périodique

As we begin the fourth decade of the epidemic, it is clear that, as demonstrated by the articles in this Special Issue, much has been learned about factors contributing to the decline in HIV prevalence among drug users in New York. However, ther[...]

Plus d'info

Ajouter à la sélection

Lien externe

Depression and HIV risk behavior among seattle-area injection drug users and young men who have sex with men

T. PERDUE ; H. HAGAN ; H. THIEDE ; VALLEROY L. | 2003
Périodique

ENGLISH : Psychological depression has been identified as a condition that may influence HIV risk behavior among injection drug users (IDUs) and men who have sex with men (MSM). In two Seattle studies,1,228 IDUs and 429 young MSM completed the[...]

Plus d'info

Ajouter à la sélection

Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men

T. PERDUE ; H. HAGAN ; H. THIEDE ; VALLEROY L. | 2003
Périodique

ENGLISH : Psychological depression has been identified as a condition that may influence HIV risk behavior among injection drug users (IDUs) and men who have sex with men (MSM). In two Seattle studies,1,228 IDUs and 429 young MSM completed the[...]

Plus d'info

Ajouter à la sélection

Does Bleach Disinfection of Syringes Help Prevent Hepatitis C Virus Transmission? (Letter to the Editor & Authors' response)

H. HAGAN ; H. THIEDE ; F. KAPADIA ; R. S. GARFEIN ; D. VLAHOV | 2003
Périodique

Plus d'info

Ajouter à la sélection

Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services

S. M. STRAUSS ; J. ASTONE-TWERELL ; C. E. MUNOZ-PLAZA ; D. C. DES JARLAIS ; M. GWADZ ; H. HAGAN ; A. OSBORNE ; A. ROSENBLUM | 2007
Dans BMC Health Services Research (Vol.7, n°39, 2007) Article : Périodique

BACKGROUND: In spite of the disproportionate prevalence of hepatitis C virus (HCV) infection among drug users, many remain uninformed or misinformed about the virus. Drug treatment programs are important sites of opportunity for providing HCV ed[...]

Plus d'info

Ajouter à la sélection

Lien externe

Drug treatment programs as sites of opportunity for the delivery of hepatitis C prevention education : client and staff perspectives

C. E. MUNOZ-PLAZA ; S. M. STRAUSS ; J. M. ASTONE ; D. C. DES JARLAIS ; H. HAGAN | 2004
Périodique

ENGLISH : This paper uses qualitative methods to examine both staff and clients perceptions about the delivery of hepatitis C prevention education services at their respective residential drug treatment programs. Through in-depth discussion wi[...]

Plus d'info

Ajouter à la sélection

Drug treatment programs HCV service delivery to their HCV positive clients

J. M. ASTONE TWERELL ; S. M. STRAUSS ; H. HAGAN ; D. C. DES JARLAIS | 2006
Périodique

ENGLISH : Hepatitis C virus (HCV) infection is the most common blood-borne infectious disease among drug users in the US. Drug treatment programs are ideally situated to assist their clients to obtain HCV medical and support services. Using da[...]

Plus d'info

Ajouter à la sélection

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs [Protocol]

L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN | 2016
Dans Cochrane Database of Systematic Reviews (n°1, 2016) Article : Périodique

This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]

Plus d'info

Ajouter à la sélection

Lien externe

Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities

H. HAGAN ; M. H. LATKA ; J. V. CAMPBELL ; E. T. GOLUB ; R. S. GARFEIN ; D. A. THOMAS ; F. KAPADIA ; S. A. STRATHDEE | 2006
Périodique

ENGLISH : Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depres[...]

Plus d'info

Ajouter à la sélection